InvestSMART

WELL HEALTH TECHNOLOGIES CORP (TSE: WELL) - ETF Exposure

Current share price for WELL : $4.280 0.06 (1.38%)+

Currency: CAD ($)

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It , patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.

WELL HEALTH TECHNOLOGIES CORP (WELL) ETFs

4 ETFs hold WELL HEALTH TECHNOLOGIES CORP (WELL).

ETF WELL Weight MER Yield
Dimensional Global Small Company Trust - Active ETF (DGSM) 0% 0.55% 3.92%
Vanguard MSCI International Small Companies Index ETF (VISM) 0% 0.32% 8.06%
Dimensional Global Core Eq Unhgd (Managed Fund) (DGCE) 0% 0.3% 1.3%
Dimensional Global Core Eq Aud Hgd (Managed Fund) (DFGH) 0% 0.3% 5.88%

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.